Genentech® Access to Care Foundation (GATCF)
The Genentech Access to Care Foundation (GATCF) was established to help patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and who meet specific financial and medical criteria to receive proper medical treatment.
We are committed to helping ease the financial burdens that some patients and their families may experience in gaining access to our medicines. In support of the commitment, GATCF provides free medicine to qualified patients.
- GATCF has defined specific insurance, financial and medical criteria that must be met for individual patients to be eligible for assistance
- Insurance: the patient must be uninsured or rendered uninsured by payer denial
- Financial: the patient must have an annual household adjusted gross income (AGI) < $100,000
- Medical: the patient must meet medical criteria
- Key points to remember about GATCF
- Patients are eligible for free medicine for 1 year; patients must reapply yearly
- GATCF assists with the medication only, not the administration costs
To see if a patient qualifies for GATCF, there are two forms that the doctor will need to complete. The completed forms should be faxed to 800-305-1830. For questions, please call us at 866-247-5084.
- The Statement of Medical Necessity (SMN) - a form with basic patient, insurance and prescription information used when contacting a patient's health insurance plan to determine their reimbursement coverage and eligibility for treatment
- The Patient Authorization and Notice of Release of Information (PAN) - a form signed and dated by your patient that gives written permission for GATCF to discuss his or her case with you
What is FUZEON?
FUZEON is a medicine called an HIV (human immunodeficiency virus) fusion inhibitor. FUZEON is always used with other anti-HIV medicines to treat adults and children ages 6 - 16 years with HIV infection.
FUZEON blocks HIV's ability to infect healthy CD4 cells. When used with other anti-HIV medicines, FUZEON can reduce the amount of HIV in the blood and increase the number of CD4 cells. This may keep your immune system healthy, so it can help fight infection.
Important Safety Information
What are the possible side effects of FUZEON?
FUZEON can cause serious allergic reactions. Symptoms of a serious allergic reaction with FUZEON can include:
- trouble breathing
- fever with vomiting and a skin rash
- blood in your urine
- swelling of your feet
Injection Site Reactions (ISRs)
FUZEON causes injection site reactions.
Almost all people get injection site reactions with FUZEON. Reactions are usually mild to moderate but occasionally may be severe. Reactions on the skin where FUZEON is injected include:
- pain or tenderness
- hardened skin
These reactions generally happen within the first week of FUZEON treatment and usually happen again as you keep using FUZEON. A reaction at one skin injection site usually lasts for less than 7 days. Injection site reactions may be worse when injections are given again in the same place on the body or when the injection is given deeper than it should be (for example, into the muscle).
If you are worried about the reaction you are having, call your healthcare provider to help you decide if you need medical care. If the injection site reaction you are having is severe, call your healthcare provider right away. If you have an injection site reaction, you can discuss with your healthcare provider ways to help the symptoms.
An injection site can get infected. It is important to follow the FUZEON Injection Instructions that come with your medicine to lower your chances of getting an injection site infection.
Call your healthcare provider right away if there are signs of infection at the injection site such as oozing, increasing heat, swelling, redness or pain.
Administration with Biojector® 2000
Shooting nerve pain and tingling lasting up to 6 months from injecting close to large nerves or near joints, and bruising and/or collections of blood under the skin have been reported with use of the Biojector 2000 needle-free device to inject FUZEON. If you are taking any blood thinners, or have hemophilia or any other bleeding disorder, you may be at higher risk of bruising or bleeding after using the Biojector.
Patients with HIV get bacterial pneumonia more often than patients without HIV. Patients with HIV are more likely to get bacterial pneumonia if they have any of the following: a low number of CD4 cells, increased amount of HIV in the blood, intravenous (injected into the vein) drug use, smoking or had experienced lung disease in the past. Patients taking FUZEON with other HIV medicines may get bacterial pneumonia more often than patients not receiving FUZEON. Three patients in the clinical trials who took FUZEON died of pneumonia.
It is unclear if the increased incidence of pneumonia is related to the use of FUZEON. You should contact your healthcare provider right away if you have a cough, fever or trouble breathing.
Call your healthcare provider right away if you get any of these symptoms. Discuss with your healthcare provider if you have previously taken FUZEON and experienced any of these reactions.
Tell your healthcare provider:
- if you are pregnant or plan to become pregnant. We do not know if FUZEON can harm your unborn child. You and your healthcare provider will need to decide if FUZEON is right for you. If you use FUZEON while you are pregnant, talk to your healthcare provider about how you can be in the Antiretroviral Pregnancy Registry.
- if you are breast-feeding. Do not breastfeed. We do not know if FUZEON can be passed to your baby in your breast milk and whether it could harm your baby. Also, mothers with HIV-1 should not breastfeed because HIV-1 can be passed to the baby in the breast milk.
- about all your medical conditions.
- about all the medicines you use, including prescription and non-prescription medicines, vitamins, and herbal supplements. FUZEON has not been tested with all medicines.
Other Side Effects
The following side effects were seen more often in patients using FUZEON with their other anti-HIV medicines than in patients not using FUZEON with their other anti-HIV medicines:
- pain and numbness in feet or legs
- loss of sleep
- decreased appetite
- sinus problems
- enlarged lymph nodes
- weight decrease
- weakness or loss of strength
- muscle pain
- pancreas problems
These are not all the side effects of FUZEON. For more information, ask your healthcare provider or pharmacist. If you have questions about side effects, ask your healthcare provider.
As with other anti-HIV medicines, FUZEON may strengthen the body's immune response which could uncover hidden infections. Report any new or continuing symptoms to your healthcare provider. Your healthcare provider will tell you what to do and may be able to help you with these side effects.
FUZEON is not a cure for HIV infection or AIDS, and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections. You should remain under the care of a doctor when using FUZEON.
You are encouraged to report side effects to Genentech and the FDA. You may contact Genentech by calling 1-888-835-2555. You may contact the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
For complete details on FUZEON, please see the Patient Product Information, or call 1-877-4 FUZEON (1-877-438-9366).